• Home
  • Centrient Pharmaceuticals

Centrient Pharmaceuticals

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,200-people strong with operations on four continents.

More than this, we are a pharmaceutical company with a clear Purpose: to improve lives through innovative and sustainable manufacturing of medicines.

Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.

Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.

 

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • NL
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Finished Formulation products Distributor/Buyer
Generic APIs producer
View company profile
Contact info
  • +31152793278
  • Sir Winston Churchilllaan 299, 2288 DC, Rijswijk, Netherlands
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
8 - 10 October 2024
View Exhibitor Profile

Products from Centrient Pharmaceuticals (30)

  • 6-amino-penicillanic acid (6-APA)

    Product 6-amino-penicillanic acid (6-APA)

    6-amino-penicillanic acid (6-APA)
  • Amoxicillin

    Product Amoxicillin

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin. Dosage form: capsules; film-coated tablets; tablets; oral suspension; sachets. Contact us for more information.
  • 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Product 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)
  • Amoxicillin + Clavulanic acid

    Product Amoxicillin + Clavulanic acid

    Centrient Pharmaceuticals provides wide range of drug products which includes amoxicillin + clavulanic acid. Dosage form: film-coated tablets; oral suspension; sachets; injectables. Contact us for more information.
  • Amoxicillin

    Product Amoxicillin

    Amoxicillin
  • Atorvastatin

    Product Atorvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes atorvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • Rosuvastatin

    Product Rosuvastatin

    Centrient Pharmaceuticals provides wide range of drug products which includes rosuvastatin. Dosage form: film-coated tablets. Contact us for more information.
  • 6-amino-penicillanic acid (6-APA)

    Product 6-amino-penicillanic acid (6-APA)

    Centrient Pharmaceuticals provides wide range of intermediates which includes 6-amino-penicillanic acid (6-apa). Characteristics: a crystalline powder manufactured by an enzymatic process starting from penicillin g potassium. Application: the product is used as an intermediate for the manufacture of s...
  • 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Product 7-Aminodeacetoxy-cephalosporanic acid (7-ADCA)

    Centrient Pharmaceuticals provides wide range of intermediates which includes 7-aminodeacetoxy-cephalosporanic acid (7-adca). Characteristics: a crystalline powder manufactured via a solvent free green route starting with fermentation followed by an enzymatic strep after which standard downstream processin...
  • Amoxicillin trihydrate compacted

    Product Amoxicillin trihydrate compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate compacted. Contact us for more information.
  • Amoxicillin trihydrate powder

    Product Amoxicillin trihydrate powder

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes amoxicillin trihydrate powder. Contact us for more information.
  • Ampicillin anhydrous compacted

    Product Ampicillin anhydrous compacted

    Centrient Pharmaceuticals provides wide range of semi-synthetic penicillins which includes ampicillin anhydrous compacted. Contact us for more information.
show all 30 products

Centrient Pharmaceuticals Resources (10)

  • Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech

    News Centrient Pharmaceuticals announces completion of acquisition of Astral SteriTech

    Centrient Pharmaceuticals (“Centrient”), the business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals, today announced the completion of the acquisition of Astral SteriTech Private Limited (“Astral SteriTech”).

    With the addition of Astral SteriTech’s Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin sterile injectable finished dosage forms to Centrient’s product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine.

    21 Sep 2022
  • Finished Dosage Forms Portfolio

    Brochure Finished Dosage Forms Portfolio

    Centrient Pharmaceuticals is a business-to-business provider of generics FDFs, not marketing the products ourselves. Therefore, we do not compete with our customers in the end market. All our dossiers are readily available for out-licensing to our partners worldwide. We work primarily with Europe-based FDFs manufacturers. Customers can be confident that the origin, traceability, and quality of our products are impeccable. We offer a dual sourcing strategy and procurement excellence for our third-party-produced APIs.

  • News Centrient achieves 100% PNEC compliance

    Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics. Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range.
    28 Sep 2020
  • API Product Portflio

    Brochure API Product Portflio

    We are a leading business-to-business provider of generic APIs. We help to secure patient safety, by driving Quality to the next level. Our reputation for producing high-quality generic APIs is well-known throughout the industry. Additionally, our business-to-business customers using our enzymatically produced APIs enjoy the freedom to operate, as these technologies are protected by patents.
  • Our PureActives® partnerships

    News Our PureActives® partnerships

    With our innovative enzymatic platform, we've been changing the game for sustainable antibiotics and statins production, step by step.
    28 Sep 2020
  • Overview Available MAs

    Technical Data Overview Available MAs

    Available Marketing Authorizations 
  • Centrient Pharmaceuticals to boost statins manufacturing capacity

    News Centrient Pharmaceuticals to boost statins manufacturing capacity

    Doubling our API capacity to meet the growing demand
    25 Sep 2020
  • Manufacturing sustainable antibiotics for the future

    Whitepaper Manufacturing sustainable antibiotics for the future

    Achieving a PNEC-compliant supply chain
  • Our ESG Report 2021

    News Our ESG Report 2021

    Sustainability matters a great deal to everyone at Centrient Pharmaceuticals, it is core to our mission and essential in shaping our authentic and purposeful culture. Our ESG Ambition means that we not only ‘do what we say,’ but also we are eager to share the significant progress we are making and demonstrate our strong industry leadership position by ‘saying what we do.’ We are proud to share our latest ESG Report 2021 summing up our accomplishments as a company.
    25 Sep 2020
  • Save Antibiotics Now

    Video Save Antibiotics Now